The present invention relates to a kit for treating a patient having Parkinsons disease, comprising a therapeutically effective dose of a first composition comprising safinamide, such as herein described and a second composition comprising at least one Parkinsons Disease agent levodopa/PDI such as herein described for treating or at least partially alleviating the symptoms of Parkinsons Disease, either in the same or separate packing.